Getinge receives EU MDR approval of Advanta V12 covered stent system with use for patients with renal artery stenosis and/or aortoiliac occlusive disease
Getinge announces the EU MDR certification of its Advanta V12 covered stent system, highlighting its use for patients with aortoiliac occlusive disease, including lesions at the aortic bifurcation. This approval affirms the system's compliance with European Union medical device regulations and aligns its application, reflecting Getinge's commitment to quality and patient safety. Getinge, a pioneer in balloon-expandable covered stents, announces the recent achievement of an EU MDR certificate for Advanta V12, that now aligns the indication to Aortoiliac Occlusive Disease (AIOD).